Five analysts have recently updated their ratings on 3M (NYSE:MMM), with four maintaining an indifferent stance and one rating it as somewhat bearish. The average 12-month price target is now $103.2, up from $102.60, with individual analysts adjusting their targets both upwards and downwards. 3M's financials show a revenue decline of -3.56%, a high net margin of -24.96%, an ROE of -33.28%, an ROA of -4.21%, and a debt-to-equity ratio of 3.6, indicating mixed financial health and potential risks.